We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bovie Medical Corp. | AMEX:BVX | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.48 | 0.00 | 01:00:00 |
Bovie Medical Corporation (NYSEMKT:BVX) (the “Company”), a medical technology company and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market, today announced that management will participate in the 9th Annual Craig-Hallum Alpha Select Conference at the Sheraton New York Times Square Hotel in New York, New York. Management will host one-on-one meetings with investors at the conference on Thursday, November 15.
About Bovie Medical Corporation:
Bovie Medical Corporation is a medical technology company and the developer of J-Plasma® (marketed and sold under the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market), a patented plasma-based surgical product for cutting, coagulation and ablation of soft tissue. J-Plasma technology utilizes a helium ionization process to produce a stable, focused beam of plasma that provides surgeons with greater precision, and minimal invasiveness. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Bovie Medical Corporation website at www.boviemedical.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181031005179/en/
Investor Relations:Westwicke Partners on behalf of Bovie Medical CorporationMike Piccinino, CFA443-213-0500investor.relations@boviemed.com
1 Year Bovie Chart |
1 Month Bovie Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions